Shin’ichi Takeda

Also affiliated with Red Cross Hospital, National Center of Neurology and Psychiatry, Kushiro City General Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide”.

Exon 44 skipping in Duchenne muscular dystrophy: NS-089/NCNP-02, a dual-targeting antisense oligonucleotide

Molecular Therapy Nucleic Acids(2023)10.1016/j.omtn.2023.102034

N/A

0.396DataRank · unranked

13 citations

Yuichiro Tone, Tetsuya Nagata, Satoru Masuda, Takashi Saito, Norio Motohashi +4 more

Duchenne muscular dystrophy

Nature Reviews Disease Primers(2021)10.1038/s41572-021-00248-3

N/A

0DataRank · unranked

1289 citations

Nathalie Goemans, Shin’ichi Takeda, Eugenio Mercuri, Annemieke Aartsma‐Rus, Dongsheng Duan